Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

NCT05085665 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Loiasis

Interventions

DRUG: Ivermectin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]